About Us
Science
Base Editing
Base Editing Applications
Additional Technologies
Presentations and Publications
Pipeline
Patients
Commitment
Our Research
Expanded Access
Investors
Careers
Internships and Co-ops
Fellowships
Current Openings
Contact
Saved jobs
0
About Us
Science
Base Editing
Base Editing Applications
Additional Technologies
Presentations and Publications
Pipeline
Patients
Commitment
Our Research
Expanded Access
Investors
Careers
Internships and Co-ops
Fellowships
Current Openings
Contact
Sitemap
Privacy Policy
Cookie Policy
Terms of use
© Beam Therapeutics. All rights reserved
Search Jobs By Keywords
Search
Search
BEAM-302: A potential base editing therapeutic for alpha-1 antitrypsin deficiency (Alpha-1)
